Cart
sales@molnova.com
Rhodionin
CAS No. 85571-15-9
Rhodionin( —— )
Catalog No. M21674 CAS No. 85571-15-9
Rhodionin and rhodionin can inhibit cytochrome P450 2D6 non-competitively with high specificity which could have implications for interactions with co-administered drugs; they can significantly suppress the elevation of the postprandial blood triglyceride level suggests that they may be to the treatment of lifestyle-related diseases such as hyperlipidemia and exogeneous obesity and to health foods.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 154 | In Stock |
|
| 5MG | 155 | In Stock |
|
| 10MG | 235 | In Stock |
|
| 25MG | 397 | In Stock |
|
| 50MG | 553 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRhodionin
-
NoteResearch use only, not for human use.
-
Brief DescriptionRhodionin and rhodionin can inhibit cytochrome P450 2D6 non-competitively with high specificity which could have implications for interactions with co-administered drugs; they can significantly suppress the elevation of the postprandial blood triglyceride level suggests that they may be to the treatment of lifestyle-related diseases such as hyperlipidemia and exogeneous obesity and to health foods.
-
DescriptionRhodionin and rhodionin can inhibit cytochrome P450 2D6 non-competitively with high specificity which could have implications for interactions with co-administered drugs; they can significantly suppress the elevation of the postprandial blood triglyceride level suggests that they may be to the treatment of lifestyle-related diseases such as hyperlipidemia and exogeneous obesity and to health foods.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetP450
-
RecptorCYP450
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number85571-15-9
-
Formula Weight448.38
-
Molecular FormulaC21H20O11
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 16.67 mg/mL (37.18 mM)
-
SMILESC[C@@H]([C@@H]([C@H]([C@H]1O)O)O)O[C@H]1Oc(cc(c(C1=O)c2OC(c(cc3)ccc3O)=C1O)O)c2O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.The antioxidant and anti-inflammatory effects of phenolic compounds isolated from the root of Rhodiola sachalinensis A. BOR.Molecules. 2012 Sep 27;17(10):11484-94.
molnova catalog
related products
-
CAY10462
CAY10462 (CTK8E8405) is an effective and selective inhibitor of the 20-HETE synthase CYP4A11 with an IC50 of 8.8 nM.
-
CDD3505
CDD3505 increases high-density lipoprotein cholesterol by targeting hepatic CYP3A.
-
Liarozole
Liarozole is a cytochrome P450 (CYP450) dependent inhibitor, orally active, it also a potent inhibitor of estrogen (via inhibition of aromatase) and testicular androgen synthesis (inhibition of 17 ,20-lyase).
